Oramed Pharmaceuticals Inc (ORMP)
2.37
+0.07
(+3.04%)
USD |
NASDAQ |
May 20, 16:00
2.37
0.00 (0.00%)
After-Hours: 16:18
Oramed Pharmaceuticals Revenue (Annual): 1.34M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.34M |
| December 31, 2022 | 2.703M |
| December 31, 2021 | 0.904M |
| August 31, 2021 | 2.703M |
| December 31, 2020 | 0.904M |
| Date | Value |
|---|---|
| August 31, 2020 | 2.71M |
| August 31, 2019 | 2.703M |
| August 31, 2018 | 2.449M |
| August 31, 2017 | 2.456M |
| August 31, 2016 | 0.641M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.904M
Minimum
2020
2.71M
Maximum
2020
1.995M
Average
2.703M
Median
2019
Revenue (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 726.44M |
| Cassava Sciences Inc | -- |
| Vertex Pharmaceuticals Inc | 9.869B |
| Cormedix Inc | -- |
| Oragenics Inc | -- |